The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Fast evolution of SARS-CoV-2 BA.2.86 to JN.1 under heavy immune pressure
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity
Li, Q., Wu, J., Nie, J., Zhang, L., Hao, H., Liu, S., Zhao, C., Zhang, Q., Liu, H., Nie, L., et al. (2020) · Cell · doi:10.1016/j.cell.2020.07.012 · Cited by 1,420
Self-citationImprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution
Cao, Y., Jian, F., Wang, J., Yu, Y., Song, W., Yisimayi, A., Wang, J., An, R., Chen, X., Zhang, N., et al. (2023) · Nature · doi:10.1038/s41586-022-05644-7 · Cited by 841
Self-citationACE2 binding and antibody evasion in enhanced transmissibility of XBB.1.5
Yue, C., Song, W., Wang, L., Jian, F., Chen, X., Gao, F., Shen, Z., Wang, Y., Wang, X., & Cao, Y. (2023) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(23)00010-5 · Cited by 328
Self-citationPan, Y., Wang, L., Feng, Z., Xu, H., Li, F., Shen, Y., Zhang, D., Liu, W. J., Gao, G. F., & Wang, Q. (2023) · The Lancet · doi:10.1016/s0140-6736(23)00129-0 · Cited by 204
Antigenicity and receptor affinity of SARS-CoV-2 BA.2.86 spike
Wang, Q., Guo, Y., Liu, L., Schwanz, L. T., Li, Z., Nair, M. S., Ho, J., Zhang, R. M., Iketani, S., Yu, J., et al. (2023) · Nature · doi:10.1038/s41586-023-06750-w · Cited by 197
Characterization of the enhanced infectivity and antibody evasion of Omicron BA.2.75
Cao, Y., Song, W., Wang, L., Liu, P., Yue, C., Jian, F., Yu, Y., Yisimayi, A., Wang, P., Wang, Y., et al. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2022.09.018 · Cited by 178
Self-citationPotent cross-reactive antibodies following Omicron breakthrough in vaccinees
Nutalai, R., Zhou, D., Tuekprakhon, A., Ginn, H. M., Supasa, P., Liu, C., Huo, J., Mentzer, A. J., Duyvesteyn, H. M. E., Dijokaite-Guraliuc, A., et al. (2022) · Cell · doi:10.1016/j.cell.2022.05.014 · Cited by 176
Antigenicity and infectivity characterisation of SARS-CoV-2 BA.2.86
Yang, S., Yu, Y., Jian, F., Song, W., Yisimayi, A., Chen, X., Xu, Y., Wang, P., Wang, J., Yu, L., et al. (2023) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(23)00573-x · Cited by 162
Self-citationTransmissibility, infectivity, and immune evasion of the SARS-CoV-2 BA.2.86 variant
Uriu, K., Ito, J., Kosugi, Y., Tanaka, Y., Mugita, Y., Guo, Z., Hinay, A. A., Putri, O., Kim, Y., Shimizu, R., et al. (2023) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(23)00575-3 · Cited by 136
Jian, F., Feng, L., Yang, S., Yu, Y., Wang, L., Song, W., Yisimayi, A., Chen, X., Xu, Y., Wang, P., et al. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011868 · Cited by 124
Self-citation
Cited by
Planas, D., Staropoli, I., Michel, V., Lemoine, F., Donati, F., Prot, M., Porrot, F., Guivel-Benhassine, F., Jeyarajah, B., Brisebarre, A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46490-7 · Cited by 263
Ruiz, F., Foreman, W. B., Lilly, M., Baharani, V. A., Depierreux, D. M., Chohan, V., Taylor, A. L., Guenthoer, J., Ralph, D., Matsen IV, F. A., et al. (2024) · PLOS Pathogens · doi:10.1371/journal.ppat.1012650 · Cited by 7
Broadly potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineages
Walker, M. R., Underwood, A., Björnsson, K. H., Raghavan, S. S. R., Bassi, M. R., Binderup, A., Pham, L. V., Ramirez, S., Pinholt, M., Dagil, R., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-06951-7 · Cited by 6
Dynamic expedition of leading mutations in SARS-CoV-2 spike glycoproteins
Hasan, M., He, Z., Jia, M., Leung, A. C. F., Natarajan, K., Xu, W., Yap, S., Zhou, F., Chen, S., Su, H., et al. (2024) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2024.05.037 · Cited by 3
Metadata
- Authors
- Yang, S., Yu, Y., Xu, Y., Jian, F., Song, W., Yisimayi, A., Wang, P., Wang, J., Liu, J., Yu, L., Niu, X., Wang, J., Wang, Y., Shao, F., Jin, R., Wang, Y., & Cao, Y.
- Venue
- The Lancet Infectious Diseases
- Publisher
- Elsevier BV
- Published
- 2024-02
- Volume
- 24
- Issue
- 2
- Pages
- e70-e72
- ISSN
- 1473-3099 (ISSN-L)
- OpenAlex
- W4389819431
- Cited by
- 383
- References
- 12
- FWCI
- 71.79
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fast evolution of SARS-CoV-2 BA.2.86 to JN.1 under heavy immune pressure. https://app.cochat.ai/papers/10.1016/s1473-3099(23)00744-2
- The paper
- Yang, S., Yu, Y., Xu, Y., Jian, F., Song, W., Yisimayi, A., Wang, P., Wang, J., Liu, J., Yu, L., Niu, X., Wang, J., Wang, Y., Shao, F., Jin, R., Wang, Y., & Cao, Y. (2024). Fast evolution of SARS-CoV-2 BA.2.86 to JN.1 under heavy immune pressure. The Lancet Infectious Diseases. https://doi.org/10.1016/s1473-3099(23)00744-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.